2 天前 - … Prognostic influence of epidermal growth factor receptor mutation and radiological
ground glass appearance in patients with early-stage lung adenocarcinoma. Lung Cancer …

2 天前 - … for the Study of Lung Cancer (IASLC) and … patients with newly diagnosed lung
adenocarcinoma. However, as mentioned above, testing should also be considered in patients …

3 天前 - … In non-small-cell lung cancer (… metastatic patients. However, the response rate is
less than 50% even in PD-L1 positive tumors and larger than 10% in PD-L1 negative patients 3…

3 天前 - … in metastatic non-small cell lung cancer (NSCLC) patients … , 131 patients with
metastatic squamous cell lung cancer … nivolumab, and 129 patients were randomized to receive …

3 天前 - … Stage IV breast cancer and lung metastasis in 2019. The patient also had axillary,
subclavian, bilateral mediastinal, and pulmonary hilar lymph node metastasis. The tumor was …

3 天前 - … Immunochemistry profile was positive for CK, CK-19, TTF1 and Napsin A favoring
a diagnosis of lung adenocarcinoma which was rationalized in the lung MDT. The patient …

4 天前 - … , a high tumor budding rate, perineural invasion, and increased lymph node
metastases (our patient had lymph node metastasis in all 11 regional lymph nodes identified) [16]. …

5 天前 - … Its expression was discernibly correlated with both patient gender and
adenocarcinoma differentiation grade (P<0.05). Nevertheless, factors such as patient age, tumor …

6 天前 - … lung adenocarcinoma. They noted that since Napsin A is expressed in greater than
90% of primary lung adenocarcinomas … A for stratifying lung adenocarcinoma into different …

7 天前 - … -LCNEC) is a highly aggressive lung malignancy and accounts for nearly 2–3% of
all lung cancers. The optimal therapeutic regimen for advanced or metastatic L-LCNEC is still …